- Investors & Media
- Investors & Media
- Contact Us
This year’s event in Vienna will bring together the “who’s who” from the biotech, pharma and finance segments to allow delegates to meet more key decision makers in three days of partnering meetings than they could in a whole year.
will release financial results for the fourth quarter and fiscal year ended December 31, 2018, prior to the open of the U.S. financial markets on Tuesday, February 12, 2019..
Kamada management will host an investment community conference call on Tuesday, February 12 at 8:30am Eastern Time to discuss these results and answer questions.
The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.
The 60th ASH Annual Meeting will be held December 1-4, 2018, in San Diego, CA. The goal of the ASH annual meeting is to present the best new scientific research in all areas of hematology.
The event will feature leading public and private companies from the pharmaceuticals, biotechnology, generics, consumer health, animal health, medical technology and healthcare services sectors from the United States, Europe, Africa, Middle East, Latin America, Russia, India, Israel, China and Japan.
The two-day event will include concurrent tracks of company presentations, thematic panel discussions, and 1×1/small-group meetings. This global gathering of leading healthcare executives and institutional, private equity and venture capital investors will address near- and long-term investment opportunities and discuss the mechanisms driving global healthcare.
Moving forward from the past two successful editions of the ESOT “Bundled Meetings” (Budapest 2014 and Barcelona 2016) the TLJ2018 will serve as a new platform for speakers and participants to engage in a variety of presentations, dynamic discussions, networking opportunities, to lead a new paradigm in the field of transplantation.
Under the theme of “Transplantation Learning Journey”, a variety of targeted programs, one for each specialty, have been designed to cover the educational needs of all fields in healthcare and research with an affiliation in transplantation.
RITA is an international scientific meeting that has been held annually since 1990, the focus of which is the presentation and discussion of developments in rabies research, surveillance, control and prevention. Conference participants include researchers, academics, regulators, students, and medical, public health, and veterinary professionals, among others. The RITA conference provides unparalleled opportunities for learning of the latest developments in the field of rabies, for networking with colleagues from around the world, and for raising the profile of sponsoring agencies on the world stage. As rabies is a zoonotic disease, this conference is an excellent forum for the productive interactions between veterinary and public health professionals promoted by the One World, One Health philosophy.
Kamada is proud to be one of the supporting partners of the upcoming IDS congress.
The congress will include talks on a wide range of current topics of interest to the community, which include ground-breaking technologies, cell-based and advanced therapeutics, immunopathology of type 1 diabetes, pathways to beta cell failure, updates from the Networks – nPod, TEDDY, Trialnet and the Immune Tolerance Network, as well as an adversarial debate and a “balloon debate”. There will be ample opportunities for networking and discussion, to move towards our common goal of understanding the immunology of type 1 diabetes and how we may intervene to change the course of disease.
The MicroCap Conference is an exclusive event dedicated to connecting small and micro-cap companies with high-level, institutional and retail investors.
Kamada CEO ,Amir London, will present on October 2 at 14:00.
The conference is a three-day multitrack event, which will feature over 200 innovative industry leaders from public and private companies for an in-depth discussion of the developments and trends shaping biotechnology, specialty pharmaceuticals, medical technology, healthcare facilities and services, and life sciences tools and diagnostics.
Kamada’s CEO, Amir London, will present on: Wed, Oct 3 at 3:25-3:55 PM in Track 5 – Grand Ballroom 2.